BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Zsófia Brigitta Nagy, Barnabás Wichmann, Alexandra Kalmár, Orsolya Galamb, Barbara Kinga Barták, Sándor Spisák, Zsolt Tulassay, Béla Molnár. Colorectal adenoma and carcinoma specific miRNA profiles in biopsy and their expression in plasma specimensClinical Epigenetics 2017; 9(1) doi: 10.1186/s13148-016-0305-3
2
Guiming Chen, Jin Peng, Weiguo Zhu, Guangzhou Tao, Yaqi Song, Xilei Zhou, Wanwei Wang. Combined downregulation of microRNA-133a and microRNA-133b predicts chemosensitivity of patients with esophageal squamous cell carcinoma undergoing paclitaxel-based chemotherapyMedical Oncology 2014; 31(11) doi: 10.1007/s12032-014-0263-6
3
Shihua Yao, Tiejun Zhao, Hai Jin. Expression of MicroRNA-325-3p and its potential functions by targeting HMGB1 in non-small cell lung cancerBiomedicine & Pharmacotherapy 2015; 70: 72 doi: 10.1016/j.biopha.2015.01.013
4
Huifen Li, Weihua Huang, Rongcheng Luo. RETRACTED ARTICLE: The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1Diagnostic Pathology 2015; 10(1) doi: 10.1186/s13000-015-0323-z
5
Veronika Vymetalkova, Pavel Vodicka, Sona Vodenkova, Sergio Alonso, Regine Schneider-Stock. DNA methylation and chromatin modifiers in colorectal cancerMolecular Aspects of Medicine 2019;  doi: 10.1016/j.mam.2019.04.002
6
Wei Zhu, Xiaoliang Ji. The Impact of MicroRNA-133a on Prognosis and Clinicopathological Parameters for Digestive System Cancers: a Comprehensive Study Based on Meta-Analysis and TCGA DatabasePathology & Oncology Research 2019;  doi: 10.1007/s12253-019-00619-y
7
Alpaslan Tanoglu, Ahmet Ziya Balta, Ufuk Berber, Yavuz Ozdemir, Levent Emirzeoglu, Abdurrahim Sayilir, Ilker Sucullu. microRNA Expression Profile in Patients with Stage II Colorectal Cancer: A Turkish Referral Center StudyAsian Pacific Journal of Cancer Prevention 2015; 16(5): 1851 doi: 10.7314/APJCP.2015.16.5.1851
8
Yuzhou Wang, Jinmei Li, Hongming Chen, Yanli Mo, Haiyin Ye, Yiping Luo, Kangwen Guo, Zongjiong Mai, Ying Zhang, Baoying Chen, Yijin Zhou, Zhixiong Yang. Down-regulation of miR-133a as a poor prognosticator in non-small cell lung cancerGene 2016; 591(2): 333 doi: 10.1016/j.gene.2016.06.001
9
Lu Sun, Zhixian Guo, Jihong Sun, Jingjing Li, Zihui Dong, Yize Zhang, Jianan Chen, Quancheng Kan, Zujiang Yu. MiR-133a acts as an anti-oncogene in Hepatocellular carcinoma by inhibiting FOSL2 through TGF-β/Smad3 signaling pathwayBiomedicine & Pharmacotherapy 2018; 107: 168 doi: 10.1016/j.biopha.2018.07.151
10
Daniele Fanale, Marta Castiglia, Viviana Bazan, Antonio Russo. Non-coding RNAs in Colorectal CancerAdvances in Experimental Medicine and Biology 2016; 937: 207 doi: 10.1007/978-3-319-42059-2_11
11
Zi-Qing Yang, Chang-An Wu, Yi-Xing Cheng. Prognostic Value of microRNA-133a Expression and Its Clinicopathologic Significance in Non-Small Cell Lung Cancer: A Comprehensive Study Based on Meta-Analysis and the TCGA DatabaseOncology Research and Treatment 2018; 41(12): 762 doi: 10.1159/000492343
12
Annunziata Di Domenico, Tabea Wiedmer, Ilaria Marinoni, Aurel Perren. Genetic and epigenetic drivers of neuroendocrine tumours (NET)Endocrine-Related Cancer 2017; 24(9): R315 doi: 10.1530/ERC-17-0012
13
Shanthi Sabarimurugan, Chellan Kumarasamy, Madhav Madurantakam Royam, Karthik Lakhotiya, Gothandam Kodiveri Muthukaliannan, Suja Ramalingam, Rama Jayaraj. Validation of miRNA prognostic significance in stage II colorectal cancerMedicine 2019; 98(12): e14570 doi: 10.1097/MD.0000000000014570